Latest News
SpyGlass Pharma, Inc.
- SpyGlass Pharma, Inc. Estimates – NASDAQ:SGP
- H.C. Wainwright reiterates SpyGlass Pharma stock rating on trial data By Investing.com
- SpyGlass Pharma Announces Positive 4-Year Data for BIM-IOL System
- SpyGlass Pharma reports positive 4-year BIM-IOL data showing 37% IOP reduction, 86% off drops
- SpyGlass Pharma's BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
- SpyGlass Pharma Reports Trial of Eye Implant Lowers Pressure by 37%
- SpyGlass Pharma unveils positive 12-month data on BIM-IOL System
- SpyGlass Pharma buys lens maker AVS for $13M to secure IOL supply
- SpyGlass Pharma Acquires Advanced Vision Science, Securing Commercial IOL Supply, Accelerating Lens Portfolio Expansion
- Wilson Sonsini Advises SpyGlass Pharma on Acquisition of Advanced Vision Science
- SpyGlass Pharma Buys Goleta IOL Maker for $13M
- SpyGlass Pharma Acquires Advanced Vision Science, Inc.
Headlines from the last 30 days, linking to the original publishers. See all market news →